Control of HSC proliferation and migration by the transcription factor EGR1

转录因子 EGR1 控制 HSC 增殖和迁移

• 批准号: 7996588
• 负责人: AMY JO WAGERS
• 金额: $ 40.38万
• 依托单位: JOSLIN DIABETES CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-01-16 至 2013-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7996588
• 关键词: Animals; BMI1 gene; Binding; Biological; Biological Assay; Biological Models; Blood; Blood Cells; Blood Circulation; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Candidate Disease Gene; Cell Count; Cell Maintenance; Cell Proliferation; Cell physiology; Cells; Clinical; Data; Employee Strikes; Engraftment; Environment; Exhibits; Frequencies; Gene Expression; Gene Family; Gene Targeting; Genes; Genetic; Growth; Harvest; Health; Hematological Disease; Hematopoietic; Hematopoietic Stem Cell Mobilization; Hematopoietic stem cells; Homeostasis; Homing; Immediate-Early Genes; Infusion procedures; Label; Life; Literature; Longevity; Malignant - descriptor; Mediating; Methods; Molecular; Mus; Non-Malignant; Organ; Osteoclasts; Parabiosis; Pathway interactions; Polycomb; Process; Production; Property; Proteins; Publishing; RNA Interference; Repression; Role; Speed; Stem cell transplant; Stem cells; Testing; Transplantation; Work; Zinc Fingers; base; bone; cell growth regulation; cell motility; cell type; chromatin immunoprecipitation; clinical application; gene interaction; improved; in vivo; insight; migration; novel; peripheral blood; promoter; research study; response; self-renewal; stem cell division; transcription factor; treatment strategy

DESCRIPTION (provided by applicant): EGR1 (Early Growth Response 1) is a well-known transcription factor of the immediate early gene family. My lab recently discovered an unexpected and intriguing role for EGR1 in regulating the activity of blood- forming hematopoietic stem cells (HSC). In particular, our extensive Preliminary Data demonstrate that EGR1 normally functions both to limit HSC proliferation and to promote HSC retention in the BM niche. These findings are significant for several reasons. First, EGR1 represents one of only a few known regulators of HSC quiescence, which is critical in preserving HSC function. Moreover, EGR1 represents the first identified transcriptional regulator of HSC migration, suggesting that targeting this factor may provide novel avenues to inducing stem cell mobilization for clinical transplant. Finally, and most remarkably, the role of this single gene in determining both the proliferation and anatomical localization of HSC reveals a novel and potentially broadly acting mechanism for controlling stem cell number whereby stem cell division is molecularly coordinated with retention in the niche. Egr1-/- mice thus present an extraordinary opportunity for discovering new and important insights into the fundamental properties of HSC and their clinical applications. Through two focused and complementary Specific Aims, the work proposed in this application will (1) determine by functional analyses whether the stem cell regulatory factor Bmi1 represents a key target gene responsible for EGR1-mediated effects on HSC proliferation and localization, (2) identify and functionally validate additional, novel targets of EGR1 that regulate HSC activity, and (3) elucidate the cellular mechanism(s) underlying the spontaneous mobilization of LT-HSC in Egr1-/- mice. These studies thus take advantage of EGR1 and Egr1-/- mice as unique model system to answer long-standing questions about the molecular and cellular regulation of HSC function. PUBLIC HEALTH RELEVANCE: Egr1 represents the first known transcriptional regulator of both HSC migration and proliferation. Thus, identification of the Egr1-regulated pathways active in HSC will be vital for developing a mechanistic understanding of these processes and their role in stem cell function. These findings will have significant implications both for understanding the normal, homeostatic control of HSC activity in blood formation and for manipulating stem cell activity clinically to improve the efficiency of HSC mobilization for donor cell harvest and to speed hematopoietic engraftment following transplantation.

描述（由申请人提供）：EGR 1（早期生长反应1）是一种众所周知的立即早期基因家族的转录因子。我的实验室最近发现了EGR 1在调节造血干细胞（HSC）活性方面的一个意想不到的有趣作用。特别是，我们广泛的初步数据表明，EGR 1正常功能限制HSC增殖和促进HSC保留在BM龛。这些发现具有重要意义，原因有几个。首先，EGR 1代表了仅有的几个已知的HSC静止调节因子之一，这在保持HSC功能方面至关重要。此外，EGR 1代表了第一个确定的HSC迁移的转录调节因子，这表明靶向该因子可能为诱导临床移植的干细胞动员提供新的途径。最后，最值得注意的是，这个单一的基因在决定HSC的增殖和解剖定位的作用揭示了一种新的和潜在的广泛作用的机制，用于控制干细胞的数量，其中干细胞分裂是分子协调与保留在小生境。因此，Egr 1-/-小鼠为发现HSC的基本特性及其临床应用提供了一个非凡的机会。通过两个集中的和互补的特异性目的，本申请中提出的工作将（1）通过功能分析确定干细胞调节因子Bmi 1是否代表负责EGFR 1介导的对HSC增殖和定位的作用的关键靶基因，（2）鉴定和功能验证调节HSC活性的EGFR 1的另外的新靶点，（3）阐明Egr 1-/-小鼠LT-HSC自发动员的细胞机制。因此，这些研究利用EGR 1和Egr 1-/-小鼠作为独特的模型系统来回答关于HSC功能的分子和细胞调节的长期问题。公共卫生相关性：Egr 1是第一个已知的HSC迁移和增殖的转录调节因子。因此，鉴定HSC中Egr 1调节的活性通路对于理解这些过程及其在干细胞功能中的作用至关重要。这些研究结果将有显着的意义，理解正常的，稳态控制造血干细胞活性的血液形成和临床上操纵干细胞活性，以提高效率的造血干细胞动员供者细胞收获和移植后加速造血植入。